• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$64.85 $0.76 (1.19%)

REAL-TIME: Last trade at

Vertex Pharmaceuticals

NASDAQ:VRTX

Jump to this page for:

Related Resources

Is This Biotech's Best Stock?

5/27/2012 by DailyFinance

3 Health-Care Stocks Crushing the Market

5/26/2012 by DailyFinance

The Meaningless Drug Approval That Could Cost the Industry Billions

5/25/2012 by DailyFinance

Cramer's Lightning Round - Titan Is In-Your-Face Optimistic (5/23/12)

5/24/2012 by Seeking Alpha

Chelsea: A Short-Term Buying Opportunity

5/23/2012 by Seeking Alpha

Too Little, Too Late for Achillion?

5/22/2012 by DailyFinance

2 Reasons That Cystic Fibrosis Trumps Hep C

5/16/2012 by DailyFinance

Top Analyst Upgrades & Downgrades

5/14/2012 by 247wallst

5 of Last Week's Biggest Winners

5/14/2012 by DailyFinance

Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN

5/14/2012 by Nasdaq

Stocks Shaking the Investment World

5/11/2012 by DailyFinance

Top Analyst Upgrades & Downgrades (ARMH, BIG, CHKM, CSCO, CPWM, DLB, HGSI, JDSU, LINE, MMM, NOV, ORC

5/10/2012 by 247wallst

How High Can Vertex Pharmaceuticals Fly?

5/10/2012 by DailyFinance

This Biotech Is No One-Trick Pony

5/10/2012 by DailyFinance

Is Vertex Pharmaceuticals the Perfect Stock?

5/8/2012 by DailyFinance

Top Analyst Upgrades & Downgrades (ACM, ALNY, BIIB, BP, COF, SNP, CTSH, EA, EPB, ERJ, F, LPX, MFC, M

5/8/2012 by 247wallst

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

5/8/2012 by 247wallst

Vertex Pharma's CF Drug Outperforms - Analyst Blog

5/8/2012 by Nasdaq

Tuesday's Top Upgrades (and Downgrades)

5/8/2012 by DailyFinance

Vertex shares soar on cystic fibrosis study

5/7/2012 by MarketWatch

Why Vertex Shares Skyrocketed

5/7/2012 by DailyFinance

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

5/7/2012 by 247wallst

Vertex Pharmaceuticals and Sirius XM Radio Among Most Active Stocks in Pre-Market Today on the Nasda

5/7/2012 by Minyanville

Vertex Pharmaceuticals Soars on Cystic Fibrosis Drug Study

5/7/2012 by Minyanville

Western Markets Shake Off Euro Election Jitters: Daily Markets Wrap.

5/7/2012 by Nasdaq

The Dow Falls for a Fourth Straight Day

5/7/2012 by DailyFinance

This Just In: More Upgrades and Downgrades

5/7/2012 by DailyFinance

24/7 Wall St. Closing Bell (FSLR, PEP, PG, ILMN, CCL, ANV, AWR, BBEP, CDE, DISH, LPX, TSN, HFC, CHTR

5/7/2012 by 247wallst

Will Gilead Sciences Help You Retire Rich?

5/3/2012 by DailyFinance

Merck Beats by a Penny; Affirms View - Analyst Blog

4/27/2012 by Nasdaq

Seeing Black Gives Regeneron a 9% Pop

4/27/2012 by DailyFinance

Maybe There Will Be Some Hep C Patients Left

4/27/2012 by DailyFinance

Vertex Pharmaceuticals Earnings Preview

4/24/2012 by DailyFinance

Celebrate the Hep C Wins, for Now

4/21/2012 by DailyFinance

Gilead, Bristol Shine at EASL Conference

4/21/2012 by DailyFinance

Partner Up or Get Passed Up

4/20/2012 by DailyFinance

Vertex Reports Positive Data on Incivek - Analyst Blog

4/20/2012 by Nasdaq

Gilead Sciences Soars on Hepatitis Drug Study

4/19/2012 by Minyanville

2nd UPDATE: Gilead, Bristol's Hepatitis C Drugs Show Promise In Study

4/19/2012 by Smart Money

2 Biotechs Absolutely Crushing It

4/19/2012 by DailyFinance
See More Articles...